June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Treatment Patterns of Non-Infectious Scleritis among General Ophthalmologists
Author Affiliations & Notes
  • Alexander James Altman
    Ophthalmology, New Jersey Medical School Division of Clinical Sciences, Newark, New Jersey, United States
  • David Chu
    Ophthalmology, New Jersey Medical School Division of Clinical Sciences, Newark, New Jersey, United States
  • Footnotes
    Commercial Relationships   Alexander Altman None; David Chu None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4842. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexander James Altman, David Chu; Treatment Patterns of Non-Infectious Scleritis among General Ophthalmologists. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4842.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This study seeks to evaluate the treatment pattern for patients with non-infectious anterior scleritis who present to tertiary care eye center.

Methods : We retrospectively analyzed longitudinal data of 86 patients between (month) 2016 to (month)2022 from a tertiary uveitis practice in order to evaluate treatment patterns among referring ophthalmologists for scleritis. Inclusion criteria entailed a definitive diagnosis of anterior non-infectious scleritis after evaluation by a uveitis specialist upon initial visit. Variables collected include demographics such as age, gender, race, initial treatment when presenting to uveitis specialist, underlying immunologic diagnoses, associated ophthalmic conditions, and initial visual acuity.

Results : Of 86 patients that were referred to a tertiary uveitis practice, 46 were diagnosed correctly with scleritis and 38 were misdiagnosed as other conditions. Of the 38 that were misdiagnosed upon initial referral, 12 (31.6%) were initially on no treatment, 20 (52.6%) were on topical steroids, and 3 (8.3%) were on oral steroids. As for the patients that were correctly diagnosed with scleritis upon referral, only 11 (23.9%) were initially on an oral NSAID as part of their initial treatment regimen. 11 (23.9%) patients were on topical steroids as their only treatment.

Conclusions : Only a small percentage of patients with scleritis are started on oral NSAID’s upon initial diagnosis, despite being considered the standard of care. Scleritis is frequently undertreated.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×